Delving the depths of measurable residual disease negativity in acute myeloid leukemia

por Freeman, Sylvie D.
Publicado 2022

Role of Minimal (Measurable) Residual Disease Assessment in Older Patients with Acute Myeloid Leukemia

por Buccisano, Francesco, Dillon, Richard, Freeman, Sylvie D., Venditti, Adriano
Publicado 2018

Moving toward a conceptualization of measurable residual disease in myelodysplastic syndromes

por Schulz, Eduard, Aplan, Peter D., Freeman, Sylvie D., Pavletic, Steven Z.
Publicado 2023

Expression of CD33 is a predictive factor for effect of Gemtuzumab Ozogamicin at different doses in adult acute myeloid leukemia

por Khan, Naeem, Hills, Robert K, Virgo, Paul, Couzens, Stephen, Clark, Nithiya, Gilkes, Amanda, Richardson, Peter, Knapper, Steven, Grimwade, David, Russell, Nigel H, Burnett, Alan K, Freeman, Sylvie D
Publicado 2016

Normal Hematopoietic Progenitor Subsets Have Distinct Reactive Oxygen Species, BCL2 and Cell-Cycle Profiles That Are Decoupled from Maturation in Acute Myeloid Leukemia

por Khan, Naeem, Hills, Robert K., Knapper, Steve, Steadman, Lora, Qureshi, Ushna, Rector, Jerrald L., Bradbury, Charlotte, Russell, Nigel H., Vyas, Paresh, Burnett, Alan K., Grimwade, David, Hole, Paul S., Freeman, Sylvie D.
Publicado 2016

Prognostic value of monitoring a candidate immunophenotypic leukemic stem/progenitor cell population in patients allografted for acute myeloid leukemia

por Bradbury, Charlotte, Houlton, Aimee E, Akiki, Susanna, Gregg, Richard, Rindl, Max, Khan, Josephine, Ward, Janice, Khan, Naeem, Griffiths, Mike, Nagra, Sandeep, Hills, Robert, Burnett, Alan, Russell, Nigel, Vyas, Paresh, Grimwade, David, Craddock, Charles, Freeman, Sylvie D.
Publicado 2014

A randomized comparison of CPX-351 and FLAG-Ida in adverse karyotype AML and high-risk MDS: the UK NCRI AML19 trial

por Othman, Jad, Wilhelm-Benartzi, Charlotte, Dillon, Richard, Knapper, Steve, Freeman, Sylvie D., Batten, Leona M., Canham, Joanna, Hinson, Emily L., Wych, Julie, Betteridge, Sophie, Villiers, William, Kleeman, Michelle, Gilkes, Amanda, Potter, Nicola, Overgaard, Ulrik Malthe, Mehta, Priyanka, Kottaridis, Panagiotis, Cavenagh, Jamie, Hemmaway, Claire, Arnold, Claire, Dennis, Mike, Russell, Nigel H.
Publicado 2023

Fractionated vs single-dose gemtuzumab ozogamicin with determinants of benefit in older patients with AML: the UK NCRI AML18 trial

por Freeman, Sylvie D., Thomas, Abin, Thomas, Ian, Hills, Robert K., Vyas, Paresh, Gilkes, Amanda, Metzner, Marlen, Jakobsen, Niels Asger, Kennedy, Alison, Moore, Rachel, Almuina, Nuria Marquez, Burns, Sarah, King, Sophie, Andrew, Georgia, Gallagher, Kathleen M. E., Sellar, Rob S., Cahalin, Paul, Weber, Duruta, Dennis, Mike, Mehta, Priyanka, Knapper, Steven, Russell, Nigel H.
Publicado 2023

Augmented Reduced-Intensity Regimen Does Not Improve Postallogeneic Transplant Outcomes in Acute Myeloid Leukemia

por Craddock, Charles, Jackson, Aimee, Loke, Justin, Siddique, Shamyla, Hodgkinson, Andrea, Mason, John, Andrew, Georgia, Nagra, Sandeep, Malladi, Ram, Peniket, Andrew, Gilleece, Maria, Salim, Rahuman, Tholouli, Eleni, Potter, Victoria, Crawley, Charles, Wheatley, Keith, Protheroe, Rachel, Vyas, Paresh, Hunter, Ann, Parker, Anne, Wilson, Keith, Pavlu, Jiri, Byrne, Jenny, Dillon, Richard, Khan, Naeem, McCarthy, Nicholas, Freeman, Sylvie D.
Publicado 2021

FLT3 inhibitors as MRD-guided salvage treatment for molecular failure in FLT3 mutated AML

por Othman, Jad, Potter, Nicola, Mokretar, Katya, Taussig, David, Khan, Anjum, Krishnamurthy, Pramila, Latif, Anne-Louise, Cahalin, Paul, Aries, James, Amer, Mariam, Belsham, Edward, Conneally, Eibhlin, Craddock, Charles, Culligan, Dominic, Dennis, Mike, Duncan, Caroline, Freeman, Sylvie D., Furness, Caroline, Gilkes, Amanda, Gkreka, Paraskevi, Hodgson, Katherine, Ingram, Wendy, Jain, Manish, King, Andrew, Knapper, Steven, Kottaridis, Panagiotis, McMullin, Mary Frances, Mohite, Unmesh, Ngu, Loretta, O’Nions, Jenny, Patrick, Katharine, Rider, Tom, Roberts, Wing, Severinsen, Marianne Tang, Storrar, Neill, Taylor, Tom, Russell, Nigel H., Dillon, Richard
Publicado 2023

Gilteritinib for Relapsed Acute Myeloid Leukaemia with FLT3 Mutation during the COVID-19 Pandemic: Real World Experience from the UK National Health Service

por Othman, Jad, Afzal, Usman, Amofa, Ruebina, Austin, Michael J, Bashford, Alex, Belsham, Edward, Byrne, Jennifer, Coats, Thomas, Dang, Raymond, Dennis, Mike, Dhawan, Saniya, Elliot, Johnathon, Francis, Sebastian, Gallipoli, Paolo, Hodgson, Katherine, Kallmeyer, Charlotte, Jain, Manish, Katsomitrou, Vana, Khan, Anjum, Khwaja, Asim, Kolade, Seye, Krishnamurthy, Pramila, Latif, Annie, Laurie, John, Lim, Michael, Loke, (Justin) Ching Ting, Manson, Cara, Marshall, Scott R., Mobashwera, Behnaz, Munisamy, Sreetharan, Murray, Duncan, Murthy, Vidhya, Palanicawandar, Renuka, Saunders, Jamie, Smith, Matthew, Smith, Katherine, Sternberg, Alex, Taussig, David, Taylor, Tom, Freeman, Sylvie D, Craddock, Charles, Dillon, Richard
Publicado 2021

Venetoclax with Azacitidine or Low Dose Cytarabine As an Alternative to Intensive Chemotherapy in Fit Adults during the COVID19 Pandemic: Real World Data from the UK National Healt...

por Othman, Jad, Amer, Mariam, Amofa, Ruebina, Anderson, Laura, Austin, Michael J, Bashford, Alex, Belsham, Edward, Boot, Jesca, Campbell, Victoria Louise, Coats, Thomas, Collins, Angela, Crawley, Charles, Crolla, Francesca, Cross, Joe W, Dalley, Chris, Dang, Raymond, Dennis, Mike, Dhawan, Saniya, Elliott, Johnathon, Galli, Sofia, Gallipoli, Paolo, Hodgson, Katherine, Jain, Manish, Kalkur, Pallavi, Katsomitrou, Vana, Khan, Anjum, Khwaja, Asim, Krishnamurthy, Pramila, Latif, Annie, Laurie, John, Lim, Michael, Loizou, Eleana, Loke, Justin, Mannari, Deepak, Manson, Cara, Marshall, Scott R., Mobashwera, Behnaz, Murthy, Vidhya, Ochaya, Odong, Orthi, Shahzad, Palanicawandar, Renuka, Pillai, Srinivas, Radzova, Dominika, Rye, Adam, Saunders, Jamie, Smith, Matthew, Taussig, David, Taylor, Tom, Whitmill, Richard, Zhao, Rui, Freeman, Sylvie D, Craddock, Charles, Dillon, Richard
Publicado 2021